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Abstract
The present work focuses on the growth phase regulated expression of biopterin transporter gene (BT1) from the LD1 locus on
chromosome 35 of Leishmania donovani. Antiserum against recombinant BT1 detected a polypeptide of 45 kDa of equal intensity at lag,
log and stationary phases of promastigote growth, both in L. donovani strain LSB-7.1 (MHOM/BL/67/ITMAP263), and strain LSB-146.1
(HOM/IR/95/X81), a natural isolate from Isfehan, Iran that caused cutaneous leishmaniasis. However, in both these strains an additional
polypeptide of higher molecular mass (50 kDa) was also observed during lag phase only. In addition, polypeptides of 40, 20, 18 and 16
kDa were seen only during the lag and log phases of both strains. Analysis of L. donovani single, double and triple (null) BT1 knockout
mutants confirmed that the 45-kDa polypeptide was the BT1 gene product, as it was absent in the null mutant. These results indicate that
45-kDa BT1 protein in Leishmania is consistently and constitutively expressed in all the growth stages of the parasite. ß 2002 Federation
of European Microbiological Societies. Published by Elsevier Science B.V. All rights reserved.
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1. Introduction
Leishmania are protozoan pathogens that cause leishma-
niasis. Globally, millions of people are infected with these
parasites and options for drug treatment are limited to the
antimonial drugs. Resistance to existing drugs is a major
problem. Drug resistance in Leishmania leads to ampli¢-
cation of speci¢c genes {Beverley, CA, USA, 1991}. How-
ever, ampli¢ed DNAs have also been found in the absence
of drug pressure. The LD1 locus on chromosome 35
(chr35) is ampli¢ed in 15% of the natural isolates [1].
The complete LD1 locus, or parts of it, are ampli¢ed,
primarily as circular DNA or linear [2]. A number of open
reading frames (ORFs) with potential protein coding func-
tions have been identi¢ed from the LD1 [2,3]. Sequence
analysis and database searches revealed genes encoding
ribosomal protein L37 [4^6], a protein with homology to
sfhB gene of Escherichia coli [4], a biopterin transporter
[6,7], two GTP-binding proteins [8], and a potential pro-
tein kinase (P.J. Myler, unpublished data).
The biopterin transporter gene (BT1), initially known as
ORFG, is ampli¢ed in all strains of Leishmania showing
LD1 ampli¢cation [3] (P.J. Myler, unpublished data). It
encodes a transmembrane protein with 10^12 putative
membrane-spanning domains. These regions are predicted
to form amphiphilic K-helix or L-strands typical of type IV
integral membrane proteins. Database searches revealed
that BT1 has 34% amino acid sequence identity and
64.3% similarity with ESAG10 gene product from the
VSG expression site of Trypanosoma [6]. A unique type
of LD1 ampli¢cation was observed in Leishmania donovani
LSB-51.1, where the BT1 gene is translocated to the
rRNA locus on chromosome 27 (chr27), resulting in sub-
stantially increased BT1 transcript levels [9]. We report
here expression of a 45-kDa BT1 protein in a L. donovani
strain and a natural isolate causing cutaneous leishmania-
sis.
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2. Materials and methods
2.1. Parasite culture
The stocks used in this study were L. donovani strains
LSB-51.1 (MHOM/SD/00/Khartoum) and LSB-7.1
(MHOM/BL/67/ITMAP263 clone 10), which cause viscer-
al leishmaniasis (VL) and strain LSB-146.1 (HOM/IR/95/
X-81), a natural isolate from Isfehan, Iran that causes
cutaneous leishmaniasis (CL). The last was kindly pro-
vided by Dr. K.P. Chang (Chicago Medical School). Spe-
ciation of LSB-146.1 is not yet done. Promastigotes of the
above strains were maintained at 22‡C in M199 medium
(Gibco/BRL) supplemented with 100 Wg ml31 penicillin,
100 Wg ml31 streptomycin and 10% heat inactivated FBS
(Biological Industries, Israel). In order to examine BT1
expression at di¡erent growth phases, stationary cultures
of promastigotes were diluted 10-fold in fresh medium and
cells harvested after 24 h (lag phase), 72 h (log phase), and
120 h (stationary phase).
Deletion mutants of the BT1 transporter gene were de-
rived from LSB-51.1 by three rounds of targeted gene
replacement with puromycin, hygromycin and phleomycin
drug resistance markers, replacing the two BT1 alleles on
chr35 and the one on chr27 [7]. The single knockout mu-
tant (SKO) retained two copies of BT1, one on chr35 and
the other on chr27, the double knockout mutant (DKO)
lacked both copies of BT1 on chr35 but retained the copy
on chr27, and the triple knockout mutant (TKO) lacked
all copies of BT1. Promastigotes of these strains were
maintained at 22‡C as described earlier [7].
2.2. Immunoprecipitation of BT1 protein
Promastigotes at lag, log and stationary phase were
harvested, washed and resuspended in Hank’s balanced
salt solution (HBSS) to a cell density of 5U107 cells
ml31. 50 WCi of [35S]methionine were added to 1 ml ali-
quots of the cell suspension which were then incubated for
6 h at 22‡C, before the cells were harvested and washed
twice with phosphate bu¡ered saline (PBS), pH 7.4. The
cell pellets were resuspended in 250 Wl of lysis bu¡er (10
mM Tris, pH 7.4, 0.3% Triton X-100, 150 mM NaCl,
0.02% sodium azide, 100 Wg ml31 PMSF, 0.3% NP-40
and 2 mM EDTA) and centrifuged at 2700Ug for 5 min
at 4‡C to remove the cell debris. Incorporation of
[35S]methionine was determined by trichloroacetic acid
(TCA) precipitable radioactivity in 5 Wl of the supernatant.
For immunoprecipitation, aliquots of each sample con-
taining 106 cpm were diluted to 500 Wl with fresh lysis
bu¡er and 10 Wl of pre-immune sera were added for 1 h.
30 Wl of protein A-Sepharose (Pharmacia) was then added
and the suspensions were incubated at room temperature
for 1 h, with constant inversion of the tube, before cen-
trifugation at 2700Ug for 10 min at 4‡C. The cleared
supernatants were then immunoprecipitated with 10 Wl of
rabbit antiserum raised against recombinant protein rep-
resenting the C-terminal portion of BT1 [7]. After 2 h
incubation on ice, 30 Wl of protein A-Sepharose was added
and the suspensions were incubated for a further 1 h at
room temperature with constant shaking. Following cen-
trifugation as above, the pellet was washed twice with lysis
bu¡er, resuspended in equal volume of 2Usodium dodecyl
sulfate^polyacrylamide gel electrophoresis (SDS^PAGE)
loading bu¡er (0.15 M Tris, pH 6.8, 4.0% SDS, 20% glyc-
erol, 0.06% bromophenol blue, 1.4 M 2-mercaptoethanol)
boiled for 10^15 min and loaded on to a 10% polyacryl-
amide gel [10]. After electrophoresis, the gel was rinsed
with dimethylsulfoxide (DMSO) and incubated in ¢ve
times the gel volume of DMSO for 45 min. The gel was
then placed in ¢ve times the gel volume of 22% diphenyl-
oxazole in DMSO and incubated for 45 min at room tem-
perature with constant shaking. The diphenyloxazole im-
pregnated gel was kept in a gentle £ow of water for 30 min
to 1 h. The gel was then dried, exposed to X-ray ¢lm and
kept at 380‡C before developing.
3. Results and discussion
In order to characterize the expression of BT1 protein,
polyclonal antisera raised in a rabbit against recombinant
BT1 were used to detect [35S]methionine labeled proteins
from the lag, log and stationary phases of promastigotes
from LSB-7.1 (which causes VL) and LSB-146.1 (which
causes CL). The results are shown in Fig. 1. Similar
amounts of labeled polypeptide with an apparent molec-
Fig. 1. Expression of BT1 protein in Leishmania. Promastigotes from
strains LSB-7.1 and LSB-146.1 grown for 24 h (lag phase), 72 h (log
phase) or 120 h (stationary phase) were incubated with [35S]methionine
for 6 h and the cells were harvested. Protein extracts were mixed with a
rabbit antiserum and the protein A-Sepharose adsorbed immune com-
plexes were separated by SDS^PAGE. Molecular mass markers (Phar-
macia) are shown to the right, and the sizes of the labeled major poly-
peptides detected are shown to the left.
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ular mass of 45 kDa were observed in all the three growth
phases of both strains. In contrast, a 50-kDa polypeptide
was observed only during lag phase (24 h) in both LSB-7.1
and LSB-146.1. Four lower molecular mass polypeptides
(40, 20, 18 and 16 kDa) were also present in lag phase
parasites in both strains. The 50- and 40-kDa polypeptides
were absent in log (72 h) and stationary (120 h) phase
promastigotes, while the abundance of the 20-, 18- and
16-kDa polypeptides was considerably higher in log phase
parasites. They were all absent in stationary phase cul-
tures. The level of most of these proteins varied as func-
tion of parasites culture age. The 50-, 40-, 20-, 18- and 16-
kDa polypeptides are not due to non-speci¢c precipitation.
Even after the pre-treatment of the cell lysates with pre-
immune sera no residual complexes were observed in any
of the samples (data not shown). However one protein of
45 kDa consistently and constitutively expressed in both
the strains and also at di¡erent stages of growth phase.
The expected size of the BT1 protein predicted from the
genomic sequence is 69.7 kDa [6,7]. However, anomalous
migration of integral membrane proteins (such as the BT1)
in SDS^PAGE is not uncommon [11]. Immunoprecipita-
tion of log phase promastigotes of wild-type LSB-51.1 and
the three daughter lines with single (SKO), double (DKO)
and triple (TKO) knockouts of the BT1 gene is shown in
Fig. 2. The 45-kDa polypeptide is present in all lines ex-
cept TKO, which is a null mutant for BT1. Thus, the 45-
kDa polypeptide is indeed derived from the BT1 gene.
Interestingly, smaller polypeptides (V40 and 20 kDa)
are present in all mutants, indicating that they are not
derived from the BT1 gene. They presumably represent
polypeptides containing epitopes that cross-react with the
anti-BT1 antibodies. The variability of the immunopreci-
pitation pro¢les between the various strains might be due
to the existence of the cellular proteins with similar epi-
topes that are not related to BT1 at all.
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Fig. 2. Expression of BT1 in knockout mutants of Leishmania. Log
phase promastigotes from LSB-51.1 wild-type (WT), single (SKO), dou-
ble (DKO) and triple (TKO) knockout mutants were labeled with
[35S]methionine for 6 h, and the cells harvested. Proteins were immuno-
precipitated and separated by SDS^PAGE. Molecular mass markers
(Pharmacia) are shown to the right, and the labeled BT1 encoded poly-
peptide is shown to the left.
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